CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, cilt.23, sa.4, ss.611-621, 2014 (SCI-Expanded)
Background: Prior studies suggested that glycans were differentially expressed in patients with ovarian cancer and controls. Wehypothesized that glycan-based biomarkers might serve as a diagnostic test for ovarian cancer and evaluated the ability of glycans to distinguish ovarian cancer cases from matched controls.